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Abstract: The scaffold technology research utilizes biomimicry to produce efficient scaffolds that
mimic the natural cell growth environment including the basement membrane for tissue engineering.
Because the natural basement membrane is composed of fibrillar protein networks of nanoscale
diameter, the scaffold produced should efficiently mimic the nanoscale topography at a low
production cost. Electrospinning is a technique that can achieve that. This review discusses the
physical and chemical characteristics of the basement membrane and its significance on cell growth
and overall focuses on nanoscale biomimetic synthetic membrane scaffolds primarily generated using
electrospinning and their application in drug delivery and tissue engineering.
Keywords: basement membrane; BM; fiber; nanofibers; electrospun; scaffold
1. Introduction
Engineering synthetic membrane scaffolds for in-vitro tissue growth constitutes a large portion
of research in the field of biomaterial sciences [1]. The major challenge in this field is to mimic the
three-dimensional (3D) topography of the natural cellular microenvironment, which has a significant
role in modulating cell behavior [2]. The physical and chemical signals from these microenvironments
regulate the gene and protein expression, as well as proliferation, differentiation and migration of
cells [2].
The basement membrane (BM) is a highly specialized supporting structure of the extracellular
matrix to which the cells adhere [3]. Currently, there is a significant need to fabricate in-vitro
tissue models, including mucosal models that emulate the in vivo tissue to study drug delivery,
entry mechanisms of infectious agents and nutrition transport [4–7]. This can only be achieved by
fabricating a synthetic BM which promotes efficient cell proliferation, migration, and differentiation [3].
Currently, there are several nanofabrication techniques that are capable of producing 3D scaffolds with
varied dimensions (nanometer to micrometer size) and geometry (varied pore size and topographical
patterns) [8]. They range from traditional techniques such as particle leaching (i.e., porous polymer
matrix produced by leaching of porogen) and freeze drying (i.e., using thermodynamic instability
to create a porous matrix) to more advanced and controlled techniques such as lithography (pattern
transfer method) and bioprinting (3D printing of prepolymer solution in a layer-by-layer process) [8,9].
However, electrospinning is still considered a popular, low-cost and effective technique to fabricate a
synthetic BM with nano-scale topography [10].
This review discusses the physical and chemical characteristics of the basement membrane, its
significance on cell growth and an overall focus on biomimetic synthetic membrane scaffolds in the
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nanometer to micrometer scale primary generated using electrospinning and their application in drug
delivery and tissue engineering.
2. Understanding the Basement Membrane
The BM is a specialized form of an extracellular matrix (ECM) found underneath all polarized
epithelial cells of eumetazoans [11–13]. It is a dynamic structure that is constantly deposited and
modified by the epithelial cells, endothelial cells and fibroblasts [12,14]. The BM not only provides
mechanical support to the overlying tissues but also regulates tissue architecture and its function
by interacting with the cells and the surrounding environment [12]. Hence, there is a variation in
the BM thickness, composition and function with its location (cell type), physiological state and
pathophysiological state [12,15].
BM is broadly divided into three layers, namely lamina lucida, lamina densa and lamina
fibroreticularis. Of the three, lamina densa is the most important layer, which is separated from
the cells and the extracellular matrix by lamina lucida and lamina fibroreticularis, respectively [11].
Lamina lucida is a less dense zone, through which the components of lamina densa interact with the cell
surface receptors (integrin and non-integrin proteins) [11,16] The thickness of lamina fibroreticularis,
on the other hand, varies from place to place with a well-demarcated structure under the respiratory
epithelium to entirely absent in capillary walls of the kidneys [11].
The core components of lamina densa are type IV collagen, laminin, nidogen, and heparin
sulfate proteoglycan/perlecan of which type IV collagen and laminin form two independent,
self-polymerizing networks that are connected to one another by nidogen and perlecan [17]. Laminin is
a heterotrimer made of α, β and γ chains, which form a cruciform structure, whereas type IV collagen
is a heterotrimer made of three different types of alpha chains [16]. The complex assembly of the BM
is initiated by the binding of laminin to cell surface receptors such as sulfated glycolipid, integrin,
and dystroglycan [18]. Once bound, a cascade of reactions takes place starting with self-polymerization
of laminin, accumulation of other core components, bridging of laminin to type IV collagen by nidogen
and polymerization of type IV collagen to form the covalently stable network [18]. Although this
network provides the BM with its characteristic mechanical strength, their receptor binding and cell
signaling properties differ with the kind of core component isoforms [18]. For instance, there are three
isoforms of type IV collagen and 16 different isoforms of laminin distributed in different BM in a
tissue-specific manner, imparting it with its unique structure and function [19]. Other components
of BM are collagen III, collagen V, collagen VI, collagen VII, collagen XVII and collagen XVIII [19].
The BM is also a reservoir filled with growth factors such as transforming growth factor β, fibroblast
growth factor, vascular endothelial growth factor, and heparin epidermal growth factor, as well as
various proteases and cytokines, making it the most complex structure to be synthetically replicated
in-vitro [11,19,20]. Moreover, their dynamic nature and modification with age and disease adds to
the challenge.
Nanotopography of the BM plays a very important role in cell growth and function [21].
The nanoscale variations on the surface present the cell with contact guidance, which modulates the
cellular response in many ways [21]. Similarly, the size, geometry, roughness, stiffness, and porosity of
the synthetic scaffold significantly control the cell behavior [22,23]. Hence, to efficiently fabricate a
synthetic membrane in vitro, it is important to understand the topography of the native BM.
Generally, BM is considered to be of <100 nm thickness with 400 nm long collagen IV forming a
flat horizontal stretch along the interconnected network [24,25]. However, this configuration of the BM
does not provide the amount of flexibility required during tissue growth and for organs (e.g., skin,
lung, and vasculature), which are constantly changing their shape [26]. However, as discussed above,
the thickness of the BM increases with age, providing the flexibility that is otherwise impossible for
a <100 nm thick membrane [27,28]. Moreover, type IV collagen was proposed to be in a mesh-like
configuration, providing extensibility for growth and development [28].
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Stiffness and roughness are the two other factors that govern the attachment of cells on the BM.
There are two sides to the BM: the epithelial side, which is attached to the cells, and the stromal side
facing the extracellular matrix [29,30]. Recently, atomic force microscopy (AFM) study to determine
the polarity of both sides showed that the epithelial side is around two to four times stiffer than the
stromal side [29,30]. It was also determined that laminin is more localized to the epithelial side of the
BM and collagen to the stromal side [30,31]. Similarly, AFM study of the inner limiting membrane
(ILM- the BM at the vitreal surface of the human retina) indicated the retinal side (cellular side) to be
significantly rougher compared to the vitreal side (stromal side) [29].
2.1. Influence of Age on the Basement Membrane
Cardiello et al. (2010) studied the ILM of different age groups (samples from fetal stages to 90
years old) [27]. He observed that there is a steady increase in ILM thickness, from 70 nm at fetal
stages to 1500 nm by 83 years of age. Biochemical changes, such as a relative increase in type IV
collagen with a decrease in laminin concentration, was also observed [27]. On the other hand, a similar
study on human skin epithelial BM showed an inverse relationship between the concentration of type
IV collagen and BM thickness [32]. It was observed that collagen content in the skin BM decreased
with age as the total thickness increased suggesting a decrease in tissue turnover [32]. Age-related
increase in thickness was also demonstrated in the BM of human corneal epithelium [33], rat testis [34]
and rat glomerular BM [35]. In the human corneal epithelial BM, two processes of age-dependent
thickening were observed. From the fetal stage to the first 20 years continuous deposition of membrane
components onto the unilaminar membrane was the prime cause of thickening [33]. However, after
that stage, reduplication of the membrane was the main reason for thickening during which the
unilaminar membrane was converted to multilaminar BM [33]. All the above data clearly demonstrate
that, with age, there is a steady increase in BM thickness along with significant biochemical changes
such as a difference in protein concentration.
2.2. Influence of Disease on the Basement Membrane
The significance of the BM and its change with the disease was first established in Alport syndrome
(progressive loss of kidney function), caused by the mutations in alpha 3, alpha4 and alpha 5 type
IV collagen genes (COL4A5, COL4A3 or COL4A4) coding for Type IV collagen [36]. This causes
progressive thickening and multilamellation of the glomerular BM [37]. Since then, many human
genetic diseases, such as Pierson syndrome (abnormalities in eye and kidney failure), Knoblock
syndrome (eye diseases), HANAC syndrome (Hereditary Angiopathy with Nephropathy, Aneurysms
and Muscle Cramps), merosin deficient congenital muscular dystrophy and epidermolysis bullosa
(skin fragility disorder), caused by mutations in BM components, were observed [36]. Inflammatory
diseases such as asthma (airway inflammation) and collagenous colitis (nonspecific inflammatory
bowel diseases) are also known to be associated with an increase in the thickness of the subepithelial
BM [38,39].
Different cells such as leukocytes, trophoblasts, and cancer cells are known to breach the BM [13].
For instance, neutrophils and monocytes pass through the discontinuous patchy regions of the BM
called “low expression regions” during inflammation [15]. On the other hand, cancer cells gradually
change the composition of the stroma and increase the number of fibroblasts and macrophages with
the eventual release of protease and tumor invasion [15].
2.3. Importance of Basement Membrane in Tissue Engineering
BM plays a vital role in shaping tissue architecture [12]. For instance, deposition of BM protein
laminin during the development of Madin-Darby Canine kidney cells in vitro was observed to inflict
polarization of cells. This, in turn, helped in organizing the group of cells into a cyst-like monolayer,
with a lumen [40]. Laminin accumulated side of the cell became the basolateral domain and the
cell surface facing the lumen became the apical domain. Another important function of BM was
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observed in vertebrate and invertebrate embryo where the constrictive force exerted by the type
IV collagen restricted the growth along the dorsal ventral axis while permitting anterior–posterior
elongation [41,42]. Moreover, remodeling of the BM is another well-known function that brings stable
connections between two adjacent tissues [12,43]. This clearly signifies the importance of BM as a
scaffold in the field of tissue engineering.
2.4. Importance of the Basement Membrane in Drug Delivery
In the field of macromolecule and nanomedicine drug delivery, the molecular barrier is extensively
researched with the view of achieving non-invasive delivery of the therapeutics [3,44] and the
understanding of some of the component barriers of the mucosae has helped in developing effective
drug delivery strategies against these barriers [45]. However, the barrier function of BM in drug
delivery studies is a field that is not fully appreciated. An earlier study by Alfano et al. observed the
penetration of smaller macromolecules of size 5kDa was restricted by non-keratinized oral mucosal
epithelial BM [46]. A more recent study by Vllasaliu et al. using decellularized BM produced by airway
epithelial cells also demonstrated the size dependent restriction of macromolecular diffusion [3]. Both
studies clearly signify the importance of BM as a drug delivery barrier and hence further research on
its barrier function is mandatory to build efficient mucosal drug delivery strategies.
3. Electrospinning
Electrospinning is a rapidly-emerging but old technique which was first observed a century
ago [10]. Since then, it has been rediscovered and constantly refined. Currently, electrospinning
can produce high-quality fibers with nanoscale diameter from a variety of natural and synthetic
polymers [10,47]. The electrospinning equipment is simple with just four major components: a high
voltage power supply, a syringe pump, a spinneret and a collector) [10,48]. When a high voltage
is passed on to the spherical droplet of viscoelectric fluid (polymer dissolved in a suitable solvent),
pumped through a spinneret, the surface of the droplet will be covered by electric charge [10]. This
charge on the surface instantly start repelling the surface tension which holds the droplet in its sphere
shape. Once the repelling force overcomes the surface tension, the spherical drop will deform into a
conically shaped structure called Taylor cone with the eventual release of a jet of fibers as the solvent
evaporates [10]. The combined action of the electric field, repulsion forces and the whipping motion
of the fiber jet remarkably reduces the diameter of the fiber to a nanoscale dimension [10]. These
nanofibers offer a very high surface area to volume ratio. Moreover, their properties can be easily
tuned by varying the electrospinning parameters and solution properties, making it the most versatile
method for producing fibers of submicron range at a very low cost [47,49]. Hence, nanosized materials
made by electrospinning have a broad range of application in the electronics, biomedical sciences,
biotechnology, textile, energy and environmental sectors [50–55].
3.1. Biomimetic Applications of Electrospun Nano Structures for Tissue Engineering Purposes
The tissue engineering application of the electrospun nanofibrous scaffolds is attributed to its
ability to mimic the biological environment (BM or ECM) which provides both the biochemical
and biophysical information required for efficient cell adhesion, proliferation, differentiation and
migration [48–50]. This biomimetic ability of the electrospun scaffold has been harnessed in the
field of tissue engineering to regenerate various tissues such as muscle, bone, skin, cartilage, nerve,
ligament and liver [48–50]. Biomimetic nanofibrous scaffolds produced by electrospinning can be
broadly classified into three major types based on the type of polymer used: electrospun nanofibrous
scaffolds based on natural polymers, scaffolds fabricated from synthetic polymers and scaffolds made
by co-spinning both natural and synthetic polymers [54].
Electrospun nanofibers of 500–800 nm diameter with high porosity and effective mechanical
property were produced by Li et al. using poly (lactic-co-glycolic acid) (PLGA) [55]. They showed that
the nanofibers promoted cell adhesion due to their close resemblance to the nanoscale environment of
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the extracellular components [55]. This preference for cells to adhere and spread in nanoscale fibers was
also observed in mouse fibroblast cells seeded on PLGA nanofibers and smooth muscle cells seeded on
PLCL clearly indicating that the nano-topography of the BM and the ECM has to be replicated in vitro
to successfully influence cell adhesion, proliferation, and phenotypic behavior [55,56].
Poly (ε-caprolactone) (PCL) is another synthetic thermoplastic polymer that is extensively used
in tissue engineering to make nanofibrous scaffold. Cells seeded on PCL nanofibers have displayed
maturation and differentiation [54]. For instance, fetal bovine chondrocytes matured and started
expressing type II collagen when seeded on to PCL nanofibers. Similarly, human marrow stromal cells
differentiated into different cell lineages (adipogenic and chondrogenic) based on the type of culture
media, when seeded on nanofiber PLC scaffolds [57,58].
The nanofibers made of natural polymers not only mimic the nanoscale topography of the BM
and ECM components but also it has the inbuilt biological and chemical properties for cell adhesion
and growth. Collagen is one such example, which is one of the most abundant structural proteins
in vertebrates [59]. It is made up of three long polypeptide chains twisted to each other in a triple
helix structure providing it with its characteristic mechanical strength and elasticity [57]. Collagen
types I, II, III and IV are commonly used to make nanofibrous scaffolds [59,60]. Collagen nanofibers of
diameters 250 nm (type III) and 100 nm (type I) were produced by Matthews et al., which exhibited
successful adhesion and penetration of aortic smooth muscle cells. He observed that the property
of the fibers largely depends on the type of collagen used [61]. Moreover, they exhibited successful
adhesion and penetration of aortic smooth muscle cells into the engineered matrix. Collagen IV in
hexafluoroisopropanol (HFIP) solvent also demonstrated the production of fibers in a size range
from 100 nm to 2 µm [62]. To increase the stability, elasticity and tensile strength of the collagen
fibers, crosslinking agents such as glutaraldehyde, 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide
hydrochloride (EDC) and genipin (natural crosslinking agent from fruits of Gardenia jasminoides) are
also in use [52,60].
Similarly, other natural polymers such as gelatin (denatured collagen), elastin (a structural protein
in the ECM of connective tissue), silk fibroin, fibrinogen (plasma serum protein), laminin, chitin,
and chitosan are also used to successfully produce electrospun nanofibers, and as scaffolds for efficient
cell growth [60].
Natural polymers are biocompatible with inherent cell adhesion properties and are less
immunogenic when compared to synthetic polymers [47]. However, the fibers produced from these
materials are not as strong as synthetic counterparts. Furthermore, they also exhibit uncontrollable
degradation rates [60]. On the other hand, the mechanical properties and degradation rates of synthetic
polymers can be easily modified [60]. Hence, currently, a blend of both natural and synthetic polymers
is largely preferred to fabricate electrospun nanofibers to exploit their respective strengths [60]. He et al.
co-electrospun collagen type I with poly (L-lactic acid)-co-poly(ε-caprolactone) (PLLA-CL) to produce
nanofiber scaffolds, which enhanced the growth of human artery endothelial cells [63]. Another
method to use multiple polymers is by layering individual fiber meshes one on top of another by
sequential electrospinning. This was performed by Kidoaki et al. by making a tri-layered scaffold
composed of nano- and microfibrous mesh of styrenated gelatin, type I collagen and segmented
polyurethanek which mimicked the native environment of arteries [64]. PCL/collagen composites
are one of the most extensively studied polymer blends that can be easily electrospun into nanosized
fibers (210–225 nm), known to withstand high-pressure flow and proven to have in vivo stability [64]
A significant increase in cell proliferation was also observed with these systems when compared
to that of pure PCL nanofibers [64]. Gelatin is a cheaper alternative to collagen which has similar
biochemical property, but higher tensile moduli than collagen [60]. It has also been electrospun with
PCL to produce nanofibers and was observed that with an increase in total polymer concentration there
is a proportional increase in fiber diameter [60,65–67]. Table 1 lists the recent examples of different
electrospun scaffolds made of collagen, gelatin or laminin.
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Table 1. Examples of electrospun nanofibrous scaffold for tissue engineering purpose, the polymers
used along with the properties and application of the scaffold.
Composition of
Nanofibers Applications Property Author Year
PCL/gelatin
composite
Nerve tissue
engineering—Human
Scalp Adipose-Derived
Mesenchymal Stem
Cells (SADS)
Nanofibrous scaffold coated with
platelet rich plasma. Cell
proliferation and differentiation
into neural cells observed.
Fesharaki et al. [65] 2018
PVA/collagen
composite
Human lung epithelial
cell A549
Glutaraldehyde crosslinking,
epithelial mesenchymal transition
observed in nanofibers with a 170
nm average diameter
Li et al. [68] 2018
PMMA coated
with collagen and
laminin
Human myoblast and
fibroblast cell growth
PMMA average fiber diameter =
360 nm, Genipin was used as a
crosslinking agent, collagen
promoted fibroblast proliferation
and laminin promoted
myoblast proliferation
Zahari et al. [63] 2017
PLA Neural tissueengineering
PLA functionalized with
polyallylamine and epidermal
growth factor was covalently
grafted to the amine group
Haddad et a l. [69] 2016
PCL/collagen
composite
Human Wharton’s jelly
mesenchymal stem
cells
Fiber diameter = 542–633 nm Lafond et al. [70] 2015
poly (L-lactic
acid)/gelatin
Vascular tissue
engineering—Human
umbilical vein
endothelial cells,
smooth muscle cells
Fiber diameter = 100–500 nm Shalumon et al.[71] 2015
PLGA/gelatin Stem cell culture
Fiber diameter = 267 nm, gelatin
enhanced the hydrophilicity,
the scaffold was imbedded with
mesoporous silica nanoparticles to
improve tensile strength, cell
attachment and proliferation.
Mehrasa et al. [72] 2015
PCL/gelatin
composite
Bone tissue
engineering- Human
mesenchymal stem
cells
30% to 40% gelatin in nanofibers
provided optimum hydrophilicity,
degradability and promoted
cell growth
Binulal et al. [66] 2014
PCL/laminin Human embryonicstem cell culture
Fiber diameter = 31–780 nm,
promoted peripheral
nerve regeneration
Neal et al. [73] 2014
PCL/gelatin
composite
Muscle tissue
engineering- myoblasts
Genipin as a crosslinking agent,
average fiber diameter = 250–350
nm, promising cell proliferation
Kim et al. [67] 2010
PCL Human mesenchymalcell growth
Fiber average diameter = 277 nm,
Nanofibers promote cell
attachment, spreading and
differentiation compared
to microfibers
Binulal et al. [74] 2010
PCL Human umbilical veinendothelial cells
700 nm fibers coated with
poly(dopamine)(PDA), enhanced
cell adhesion with an expression
of cell markers
Ku et al. [75] 2010
PCL, Polycaprolactone; PLA, Poly lactic acid; PLGA, Poly lactic-co-glycolic acid; PVA, polyvinyl alcohol; PMMA,
Poly(methyl methacrylate).
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Electrospinning of BM protein laminin-I was first performed by Neal et al. to produce nanofibers
about 90–300 nm diameter [73]. They observed that, unlike collagen, laminin fibers were stable in
culture without any fixation by chemical crosslinking, and human adipose stem cells showed superior
adhesion quality compared to laminin films [76]. A subsequent study by this group using PCL/laminin
blend also showed similar results [73]. BM mimics are considered as the major requirement to produce
a successful tissue engineered skin, vascular graft and invitro alveolar models [77–80]. Frazer et al.
electrospun trilayer BM mimic, made of a single layer of nanofibrous polyhydroxyvalerate, interwoven
at both sides by microfibrous poly L lactic acid. This BM mimic not only increased the attachment
and proliferation of keratinocytes and fibroblasts but also encouraged the self-sorting of these cells
into epithelial and dermal layers [77]. Similarly, a BM substitute produced by coelectrospinning a
tripeptide derived from BM type IV collagen, along with PCL had an innate ability to control the ratio
of endothelial to smooth muscle cells, a characteristic feature required to produce a successful vascular
graft [78]. In vitro alveolar models to study the lung physiology and lung inflammatory reactions have
also used electrospun BM mimics [79,80]. It was observed that epithelial and endothelial cells grown
on these BM mimic better replicate the alveolar environment and its functions [80]. Recent studies were
successful in producing poloxamer 188 based nanofibers by co-electrospinning it with other polymers
(polyacrylonitrile, poly(vinyl alcohol)/poly(vinyl pyrrolidone)-iodine) [81,82]. Poloxamer 188 is a
non-ionic surfactant, which can increase the viability and proliferation of cells that were damaged due
to multiple sub-culturing, pipetting, cryostorage and thawing [83].
To impart complex spatial arrangements and dimensions into the scaffold, different types of
electrospinning techniques have evolved, which could relatively fabricate the structural complexity of
natural ECM compared to conventional electrospinning [84]. Dual extrusion electrospinning is one
such example, which permits two different polymeric solutions to be electrospun simultaneously using
different extrusion conditions [85]. This was performed by Kim et al. whose hybrid scaffold made of
silk fibroin nanofibers and PCL microfibers showed an increase in osteoblast cell differentiation [86].
Coaxial electrospinning is another technique which uses two different polymer solutions. However,
they are fed into the spinneret as inner and outer fluid to produce fibers with a different core and shell
composition [87]. This feature has increased its significance not only in the field of tissue engineering
but also in drug delivery, as these fibers have the capacity to encapsulate drugs, growth factors and
antibiotics [87]. Temperature-assisted electrospinning methods such as cryogenic electrospinning
and melt electrospinning are also used and can program the desired porosity into the scaffold [88,89].
Cryogenic electrospinning method uses ice crystals, spun along with the fibrous scaffold, which when
removed by freeze drying leave behind voids through which cells can infiltrate [88]. The porosity
can be controlled based on the size and amount of the ice crystals used [88]. Temperature-assisted
electrospinning, on the other hand, uses a melt blowing technology, where the polymer is melted with
high temperature and is extruded out using controlled air flow [89]. This method can produce aligned
fibers with desired porosity and hence was used to replicate the ECM environment of tendons [89,90].
However, none of the above methods provide complete control over the fiber alignment and its 3D
deposition. This has led researchers to use 3D printing technology in electrospinning [91,92]. Near
field-electrospinning is a relatively new method that prevents the bending and splitting instabilities of
the electrospun fibers by reducing the distance between the spinneret and collector to a bare minimum
(<3 mm). Lu et al. included a 3D printing technology into this method by controlling the fibers
deposition in a pre-programmed X-Y path [91]. Fattahi et al. went a step further and used X-Y-Z
moving stage (which replicates the technology used in hobbyist grade 3D printers) to produce a highly
organized scaffold with 3D architecture [92]. More recently, a technique referred to as 3D jet writing a
modified electrospinning process, which yields 3D structures and scaffolds that have been shown to
support the 3D expansion and differentiation of human mesenchymal stem cells in vitro (Figure 1) [93].
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Figure  1.  In  vitro  hMSC  culture  on  3D  jet writing  scaffolds produces  3D microtissues.  (A,B)  3D 
microfiber scaffolds were incubated with fibronectin and seeded with hMSCs to yield confluent cell 
structures.  (C–E) hMSCs cultured on  scaffolds  (E)  reveal  significantly different morphologies and 
spatial distribution (3D) than cultures on glass (C), or nonwoven PLGA fiber mats (D) (both 2D). (F–
H) hMSCs  on  scaffolds were  incubated  in osteogenic differentiation media  and monitored using 
qPRC.  The  markers  SP7  (F),  RUNX2  (G),  and  BSP  (H)  were  used  as  indicators  of  osteogenic 
differentiation. Values reported are  fold  increases over hMSCs cultured  in growth medium. Large 
increases in these markers after three weeks are consistent with the onset of osteogenesis. Error bars 
represent ± Std. Dev  from  three  independent experiments.  (I) Fluorescent staining of scaffolds  for 
hydroxyapatite  reveal  substantial  increases  in  matrix  mineralization  after  two  weeks  of 
differentiation. (J,K) Von Kossa staining of hMSCs incubated in growth medium (J) show little matrix 
mineralization  compared  to  that  seen  in  samples  differentiated  in  osteogenic  induction medium 
indicated  by  the  black  aggregates  (K).  Scale  bars  represent:  500  μm  (A,B);  50  μm  (J,K);  and  the 
spacings between large grids are 20 μm (C–E). Reproduced with permission from [93], Copyright 
WILEY‐VCH Verlag GmbH & Co. KGaA, 2018. 
All  the  above  examples  clearly  indicate  the  rapid  progression  of  research  in  the  field  of 
electrospinning and scaffold technology to produce a structurally programmable and low‐cost ECM 
or BM mimics for tissue engineering applications. 
3.2. Applications of Electrospun Nano Structures for Drug Delivery Purposes 
i 1. it h S cult re on 3D jet writing scaf olds produces 3D microtis ues. ,
fi ere incubated with fibronectin and see ed with hMSCs to yield confluent
cell s ructures. (C–E) hMSCs cultured on scaffolds (E) reveal significantly different morphologies
and spat al dis ribution (3D) than cultures on glass (C), or no woven PLGA fiber mats (D) (both
2D). (F–H) hMSCs on scaffolds were incubated in osteogenic differe tiation me ia and monitored
using qPRC. The markers SP7 (F), RUNX2 (G), and BSP (H) w re used as i icators oste i
f l i r h s c lt re in gro th ediu .
i i t ft t r c sist t it t set of osteo e esis.
. f
r a atite reveal sub tanti l increases in matrix mineralizat on fter wo weeks of differentiation.
(J,K) Von Kossa staining of hMSCs i cubated in growth me ium (J) show little matrix mineralization
compared to that seen in samples differentiated in o teog nic induction medium indicated by the black
aggregates (K). Scale bars represent: 500 µm (A,B); 50 µm (J,K); and the spacings between large grids
are 20 µm (C–E). Reproduced with permission from [93], Copyright WILEY-VCH Verlag GmbH &
Co. KGaA, 2018.
All the above examples clearly indicate the rapid progression of research in the field of
electrospinning and scaffold technology to produce a structurally programmable and low-cost ECM or
BM mimics for tissue engineering applications.
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3.2. Applications of Electrospun Nano Structures for Drug Delivery Purposes
Biomimetic electrospun nanofibers have the potential to be used as efficient drug carrier systems.
For instance, biomimetic electrospun polyamidoamine dendrimer/gelatin nanofibrous scaffold
carrying antibiotic doxycycline was produced by Freshwater et al., which exhibited efficient wound
healing property by controlled drug release [94]. Similarly, sandwiched electrospun ECM biomimic
made from PLGA/collagen surface and PLGA/antibiotic drug core enabled wound healing by
prolonged drug release for more than three weeks [95]. The bone ECM was mimicked in another study
where bone morphogenetic protein 2 (BMP-2) was embedded into electrospun silk fibroin/hyaluronic
acid nanofibers to use in bone repair applications [96]. Silk fibroin/hyaluronic acid biomimetic
nanofibers were demonstrated to act as excellent carriers for hydrophilic drugs [97]. This clearly
indicates the growing significance of biomimetic nanofibers in drug delivery applications.
4. Conclusions
A major challenge in creating a BM analog has been mimicking its complex chemical and physical
characteristics. Although electrospinning is a well-established technique, its use to create a BM
mimetic is in its early stages. Further research is required to optimize the electrospinning method to
produce homogeneous nanofibers with physicochemical, structural (including microscale architecture),
and biological properties that closely resemble the BM. While scaffolds made from natural polymers
are known for their innate ability to promote cell growth, they are currently less preferable due to lower
stability and faster degradation rates. However, with continuous advancement in the electrospinning
technique, production of synthetic alternatives that more closely resemble the native BM is becoming a
viable perspective. The ultimate goal is to produce synthetic BM mimetics at a low cost with versatile
applications in the field of regenerative medicine and for the creation of improved in vitro models.
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